Gliptin Accountability in Mucous Membrane Pemphigoid Induction in 24 Out of 313 Patients

Gliptin Accountability in Mucous Membrane Pemphigoid Induction in 24 Out of 313 Patients

Mucous membrane pemphigoids (MMPs) and bullous pemphigoid (BP) are autoimmune bullous diseases that share physiopathological features: both can result from autoantibodies directed against BP180 or BP230 antigens. An association has been reported between BP and intake of gliptins, which are dipeptidy...

Full description

Bibliographic Details
Main Authors: Olivier Gaudin, Vannina Seta, Marina Alexandre, Gérôme Bohelay, Françoise Aucouturier, Sabine Mignot-Grootenboer, Saskia Ingen-Housz-Oro, Céline Bernardeschi, Pierre Schneider, Benoît Mellottee, Frédéric Caux, Catherine Prost-Squarcioni
Format: Article
Language:English
Published: Frontiers Media S.A. 2018-05-01
Series:Frontiers in Immunology
Subjects:
autoimmune bullous diseases
mucous membrane pemphigoid
fibrosis
dipeptidyl peptidase IV inhibitor
gliptin
diabetes mellitus
Online Access:https://www.frontiersin.org/article/10.3389/fimmu.2018.01030/full

Internet

https://www.frontiersin.org/article/10.3389/fimmu.2018.01030/full

Similar Items